Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 0.9400
+0.0100 (1.08%)
Jul 31, 2026, 4:08 PM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 678.5 million as of July 31, 2026. Its market cap has decreased by -54.65% in one year.
Market Cap
678.50M
Enterprise Value
-1.53B
Revenue
39.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.94
ChartMarket Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 678.50M, a decrease of -95.81%. That is a compound annual growth rate of -46.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 678.50M | -33.28% |
| Dec 31, 2025 | 1.02B | 41.89% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cloudbreak Pharma | 988.14M |
| Sunho Biologics | 970.43M |
| Cutia Therapeutics | 850.28M |
| Kintor Pharmaceutical | 839.48M |
| Wuhan YZY Biopharma | 715.30M |
| JW (Cayman) Therapeutics Co. | 653.49M |
| Shanghai Bio-heart Biological Technology | 552.56M |
| 3D Medicines | 531.19M |